CSI Market
Sign In | Register

Medwellai Inc (INTV) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access INTV quarterly Cash Flow →
This cash flow overview for Medwellai Inc spans from Jun 30 2021 to Jun 30 2025, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
12 Months 		(Jun 30 2024) (Jun 30 2023) (Jun 30 2022) (Jun 30 2021)
Operating Activities
Income-2.95
Depreciation & amortization0.03
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.75
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Intangible Assets0.02
Share-based Compensation0.60
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.06
Fixed Asset Write Down-
Interest Expense Other-
Shares Payable-
Stock Issued During Period Value Conversion Of Notes To Shares-
Bcf Expense-
Oid Expense-
Change In Fv Of Embedded Conversion Options-
Stock Issued During Period Value Issued For Services-
Interest And Fee Income Loans And Leases-
Change In Fair Value Of Derivative Liability-
Marketable Securities Realized Gain Loss-
Gain Loss Related To Litigation Settlement-
Stock Based Compensation Related Party-
Financing Fees Related To Notes Payable-
Gain Loss On Exchange Of Series B Preferred Stock-
Loss On Settlement Of Warrants-
Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Adjustment-
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss-
Stock Issued During Period Value Share Based Compensation-
Increase Decrease In Due To Related Party0.28
Increase Decrease In Deposit-
Income taxes0.00
Realized Investment Gains (Losses), Total0.00
Increase (Decrease) in Receivables0.00
Increase (Decrease) in Accounts Payable0.10
Increase (Decrease) in Accrued Liabilities0.04
Payments for (Proceeds from) Other Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.12
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.10
Discontinued operations0.00
Net Cash flow from Operating Activities-0.85
Investing Activities
Capital Expenditures-0.19
Sale of Capital Items8.38
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase In Notes Receivable Related Party-
Restricted Cash And Cash Equivalents At Carrying Value-
Purchase Of Digital Currencies-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale of Long-term Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired-0.25
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-6.75
Discontinued operations0.00
Net Cash Flow from Investing Activities1.19
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Increase Decrease In Distribution-
Proceeds From Stock Subscriptions Payable-
Proceeds From Stock Subscriptions-
Proceeds From Ppp Loan Payable-
Proceeds From Issuance Of Preferred Stock And Preference Stock-
Proceeds From The Issuance Of Series C Preferred Stock-
Proceeds From The Issuance Of Series D Preferred Stock And Warrants-
Repayment Of Convertible Notes Payable-
Proceeds From The Issuance Of Series C Preferred Shares-
Proceeds From The Issuance Of Series D Preferred Shares-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow7.34
Total Cash Flow0.34
4 historic quarters locked

Sign in to unlock the full Medwellai Inc cash flow history.

Sign In Create Free Account

About Medwellai Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20250630)
  • Filed with the SEC: September 30, 2025
  • Source: intv_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001477932-25-007253

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License